The cell and gene therapy company is cutting 47 employees and its entire lupus program to focus resources on two CAR Ts. The ...

A new study published in The Journal of the American Heart Association provides insights to improve cardiovascular disease ...

Despite widespread vaccine availability and improved treatment strategies, certain patients with SARDs remain highly vulnerable to severe COVID-19 outcomes.

When most people think about arthritis or lupus, they picture adults. But for a small number of Malaysian children, these conditions ...

Obe-cel is under regulatory review in both the EU and the U.K., and the Company expects to receive notification of approval status from the Medicines and Healthcare products Regulatory Agency (MHRA) ...

In a new letter, published in the Journal of the European Academy of Dermatology and Venereology, members of the lupus ...

Actor Olivia Williams, known for The Crown, Rushmore, and The Ghost Writer, among other projects, has talked about her ...

China: A recent case study published in The Open Dentistry Journal sheds light on a dental issue faced by patients with ...

KRISHNAGIRI: A 15-year-old girl from Hosur who has been diagnosed with an autoimmune disease is in need of a critical ...

The U.S. Food and Drug Administration has granted regenerative medicine advanced therapy (RMAT) designation to Fate's FT819 ...

The trial will assess the therapy’s pharmacokinetics, pharmacodynamics and safety, as well as its impact on disease activity.

Shanghai Pharmaceuticals Holding Co. Ltd. has identified C-C chemokine receptor type 4 (CCR4) antagonists reported to be useful for the treatment of asthma, allergic rhinitis, atopic dermatitis, ...